<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000730162"><TermName>actinomycin D</TermName><TermPronunciation>(AK-tih-noh-MY-sin …)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat Ewing sarcoma, gestational trophoblastic tumor, Wilms tumor, and certain types of testicular cancer. It is also used to treat rhabdomyosarcoma in children. It is being studied in the treatment of other types of cancer. Actinomycin D comes from the bacterium Streptomyces parvulus. It damages the cell’s DNA and may kill cancer cells. It is a type of anticancer antibiotic. Also called Cosmegen and dactinomycin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000738131" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;actinomycin D&quot;" language="en" id="_3"/><MediaLink ref="CDR0000738132" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;actinomicina D&quot;" language="es" id="_4"/><SpanishTermName>actinomicina D</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el sarcoma de Ewing, el tumor trofoblástico gestacional, el tumor de Wilms y ciertos tipos de cáncer de testículo. También se usa para tratar el rabdomiosarcoma en niños. Está en estudio para el tratamiento de otros tipos de cáncer.La actinomicina D  se obtiene de la bacteria Streptomyces parvulus. Daña el ADN de la célula y podría destruir células cancerosas. Es un tipo de antibiótico contra el cáncer. También se llama Cosmegen y dactinomicina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2012-06-25</DateFirstPublished><DateLastModified>2012-06-20</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000720376">Dactinomycin</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
